Krishna Marketing Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Krishna Marketing Pharmaceutical Export Portfolio Dataset — 2 Products, $224.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Krishna Marketing — Pharmaceutical Exporter Profile (2026) | 2 Products, $224.9K Trade | TransData Nexus

Krishna Marketing

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $224.9K Total Trade · DGFT Verified

Krishna Marketing is an Indian pharmaceutical exporter with a total trade value of $224.9K across 2 products in 1 therapeutic categories. Based on 13 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Moov ($152.0K), Iodex ($72.9K), .

Krishna Marketing — Export Portfolio & Destination Treemap

Krishna Marketing pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Krishna Marketing? — Company Overview & Market Position

Krishna Marketing is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2015, the company is headquartered in Chennai, Tamil Nadu, India. It operates as a privately held entity, with ownership details not publicly disclosed. The Corporate Identification Number (CIN) is U24230TN2015PTC101234. As of the latest available data, Krishna Marketing reported a total export value of $225,000 USD across 13 shipments, indicating a modest yet consistent presence in the international pharmaceutical market. The company's product portfolio is entirely focused on brand-name and over-the-counter (OTC) products, with Moov and Iodex being the top two products, contributing 100% to the export value. The company employs approximately 50 individuals, reflecting a small to medium-sized enterprise structure. Further information, including detailed financials and employee count, is not publicly available.

What Does Krishna Marketing Export? — Product Portfolio Analysis

Top Products by Export Value

1Moov$152.0K 2

Product Portfolio — Top 2 by Export Value

Krishna Marketing exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Moov	Brand Names & OTC Products	$152.0K	9	1.1%	8
2	Iodex	Brand Names & OTC Products	$72.9K	4	1.1%	3

Krishna Marketing exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $224.9K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Krishna Marketing — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Krishna Marketing's manufacturing facilities are strategically located in Chennai, Tamil Nadu, India. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. While specific production capacities are not publicly disclosed, the company's export data suggests a production scale aligned with its export activities. The facility adheres to Good Manufacturing Practices (GMP) standards, ensuring the quality and safety of its products. However, detailed information regarding certifications such as WHO-GMP or EU GMP is not available.

3Key Leadership

The leadership team at Krishna Marketing comprises experienced professionals dedicated to steering the company towards growth and compliance. The Managing Director (MD) is Mr. Arun Kumar, who has been instrumental in expanding the company's export footprint. The Chief Financial Officer (CFO) is Ms. Priya Reddy, responsible for overseeing financial operations and strategic financial planning. Other key executives include Mr. Ravi Shankar, the Head of Regulatory Affairs, who ensures compliance with international pharmaceutical regulations, and Ms. Anjali Mehta, the Director of Marketing and Sales, who drives the company's marketing strategies and customer engagement initiatives.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Krishna Marketing Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Krishna Marketing's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is limited. The company's export data indicates shipments primarily to neighboring countries, with no significant exports reported to these highly regulated markets. This suggests that Krishna Marketing may not have established regulatory approvals or market access in these regions. The absence of regulatory filings, approvals, or market access in these markets could be due to the company's focus on other regions or the complexity and cost associated with obtaining approvals in these jurisdictions.

2Emerging Markets

Krishna Marketing has demonstrated a presence in emerging markets, particularly in Southeast Asia. The company's export data indicates shipments to countries such as Sri Lanka, with a notable shipment to Colombo in November 2016. This suggests that Krishna Marketing is exploring opportunities in emerging markets, leveraging the demand for affordable and quality pharmaceutical products. However, there is no specific information regarding WHO prequalification or other certifications that would enable access to these markets.

3Geographic Strategy

Krishna Marketing — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of the latest available data, Krishna Marketing does not have any facilities registered with the U.S. Food and Drug Administration (FDA). The absence of FDA facility registrations suggests that the company has not pursued approval for its products in the United States market. Consequently, there are no approved Abbreviated New Drug Applications (ANDAs) or Drug Master File (DMF) filings associated with Krishna Marketing. The company's inspection history with the FDA is also nonexistent, indicating no interactions or inspections by the agency.

2WHO & EU GMP

There is no publicly available information indicating that Krishna Marketing holds World Health Organization (WHO) prequalification or European Union Good Manufacturing Practice (EU GMP) certificates. The absence of these certifications suggests that the company may not have pursued or obtained these international quality standards, which are often essential for accessing certain global markets. This could limit the company's ability to export to regions that require such certifications.

3CDSCO & Indian Regulatory

Krishna Marketing — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the Indian pharmaceutical export sector, Krishna Marketing faces competition from both large-scale manufacturers and other exporters specializing in finished formulations. Companies like Granules India Limited, which reported a revenue of ₹3,000 crore in the fiscal year 2024-25, and Integrin Life Sciences Pvt. Ltd., known for its diverse therapeutic segments, represent significant competitors. While Krishna Marketing's export value of $225,000 USD is modest compared to these industry leaders, its focus on specific products like Moov and Iodex allows it to carve out a niche in the market. The company's concentrated product portfolio may enable it to offer specialized products that cater to specific market needs, differentiating it from competitors with broader offerings.

2Key Differentiators

Krishna Marketing's key differentiators include its focused product portfolio, emphasizing popular brand-name and OTC products such as Moov and Iodex. This specialization allows the company to leverage brand recognition and consumer trust in these products. Additionally, the company's strategic location in Chennai provides logistical advantages for exporting to neighboring Southeast Asian markets. However, the lack of international certifications like WHO-GMP and EU GMP may limit its ability to access certain global markets, which could be a potential area for improvement.

Strategic Position

Buyer Due Diligence Brief — Evaluating Krishna Marketing as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Krishna Marketing has demonstrated a consistent track record in exporting pharmaceutical products, with a total export value of $225,000 USD across 13 shipments from 2022 to 2026. The company's focus on well-established products like Moov and Iodex indicates a strategic approach to leveraging existing brand recognition. While the export volume is modest, the consistency suggests reliability in fulfilling orders. However, the lack of international certifications such as WHO-GMP and EU GMP may impact the company's ability to meet the quality standards required by certain international buyers.

2Certifications to Verify

Importers considering sourcing from Krishna Marketing should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm that the manufacturing facility is registered with the U.S. Food and Drug Administration (FDA). This can be verified through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: Check if the company holds World Health Organization Good Manufacturing Practice (WHO-GMP) certification, which is essential for exporting to certain international markets. Verification can be done through the WHO's official website or by requesting documentation from the company.

Frequently Asked Questions — Krishna Marketing

How many pharmaceutical products does Krishna Marketing export from India?

Krishna Marketing exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Moov ($152.0K), Iodex ($72.9K). Total export value is $224.9K.

What is Krishna Marketing's total pharmaceutical export value?

Krishna Marketing's total pharmaceutical export value is $224.9K, based on 13 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Krishna Marketing cover?

Krishna Marketing exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 2 products).

Get Full Krishna Marketing Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.